Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars

Exclusion Criteria

• •Participation in a study of another device or drug within 6 months prior to enrollment or during the study.
• •Having received any prior treatment for the target surgical scar.
• •Pregnant and/or breastfeeding.
• •Significant concurrent illness, malignant tumors in the target area, acute or chronic skin infection/inflammation, currently using immunosuppressive medications or currently undergoing systemic chemotherapy.
• •Current use of any medication known to increase sensitivity to light or taking prescription anticoagulation medication.
• •History of abnormal or delayed wound healing, keloid formation or pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation.
• •History of malignant skin disease, immune deficiency disorders, coagulation disorders, seizure disorders due to light, or diseases stimulated by heat, unless prophylactic measures taken prior to treatment.
• •Systemic use of isotretinoin within 6 months or corticosteroids within 12 months of study participation.
• •Anytime in life, had used gold therapy (gold salts) for disorders such as rheumatologic disease or lupus.
• •Current smoker or history of smoking within 12 months of study participation.